New PDJ news and reminders

Tympanoplasty – news and new perspectives

Techniques and biomaterials for reconstructive middle ear surgery are continuously and steadily developing. At the same time, clinical post-surgery results are evaluated to determine success or failure of the therapy. Routine quality assessment and assurance is of growing importance in the medical field, and therefore also in middle ear surgery. The exact definition and acquisition of outcome p...

Guns in the world: old news and new news.

New year, new advice, new news

We start another year with this issue of the RBO, which now contains a greater number of studies. This was decided by the Editorial Board and the new directorate of the SBOT, in view of the ever greater number of studies sent for publication: instead of more issues, a journal with a greater number of studies. The Editorial Board has been renewed through the entry of Professors Akira Ishida, Hel...

MEDICAL NEWS and VIEWS

New Drugs Drug News

474 P&T® • September 2007 • Vol. 32 No. 9 NEW DRUGS Low-Dose, 365-Day Contraceptive (Lybrel) Wyeth’s new oral contraceptive, consisting of levonorgestrel 90 mcg/ethinyl estradiol 20 mcg (Lybrel), is now available by prescription in pharmacies. This is the first low-dose combination tablet that can be taken 365 days a year, without a placebo phase or a pill-free inter val. Lybrel provides women ...